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Often, we elucidate evolutionary processes backwards, starting with eutherian mammals
and gradually climbing down the evolutionary tree to those species who have survived
since long before mammals evolved. This is also true for elucidating the evolution of spe-
cific proteins, in this case, the protein currently known as “transthyretin” (TTR). TTR was
first described in eutherian mammals and was known as a thyroxine (T4) binding protein.
However, mammals are the exception among vertebrates in respect to the function ofTTR,
as in teleost fish, amphibians, reptiles and birds TTR preferentially binds triiodothyronine
(T3), which is the active form of thyroid hormone (TH). The TTR gene possibly arose as a
duplication of the transthyretin-like protein (TLP) gene, around the stage of the agnathans.
Some vertebrate species have both the TTR and TLP genes, while others have “lost” the
TLP gene.TLP genes have been found in all kingdoms.TheTLPs analyzed to date do not bind
THs or their analogs, but are enzymes involved in uric acid metabolism; specifically, they
are 5-hydroxyisourate hydrolases. A SalmonellaTLP knock-out strain demonstrated thatTLP
was essential for the bacteria’s survival in the high uric acid environment of the chicken
alimentary tract. Many other TLPs are yet to be characterized for their function although
several have been confirmed as 5-hydroxyisourate hydrolases. This review describes the
evolution of TLP/TTR and how subtle changes in gene structure or amino acid substi-
tution can drastically change the function of this protein, without altering its overall 3D
conformation.
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THE ROLE OF TRANSTHYRETIN IN THYROID HORMONE
DISTRIBUTION
Thyroid hormones (THs) are involved in the regulation of growth,
development and metabolism. There are two main forms of THs:
3′,5′,3,5-tetraiodo-l-thyronine (thyroxine, T4) and 5′,3,5-triiodo-
l-thyronine (T3) (Figure 1). The only site of TH synthesis is the
thyroid gland, which secretes the THs (predominantly as T4) into
the blood. THs are lipophilic and preferably partition into the
lipid phase rather than the aqueous phase (1). To prevent the avid
partitioning of THs into the membranes of the first cells they
encounter, there are specific proteins in the blood that bind and
distribute THs, thereby creating a circulating pool of sufficient
size to distribute THs from their site of synthesis (the thyroid
gland) via the aqueous environment of the blood stream to their
sites of action, i.e., cells throughout the body (2, 3). In humans,
there are three TH distributor proteins in the blood: albumin,
transthyretin (TTR), and thyroxine-binding globulin. Of these
three proteins, albumin is present in highest abundance but binds
Abbreviations: TTR transthyretin, TLP transthyretin-like protein, 5-HIUase 5-
hydroxyisourate hydrolase.
THs with lowest affinity, thyroxine-binding globulin is present in
lowest abundance but binds THs with highest affinity, and TTR
is present in intermediate abundance and binds with intermedi-
ate affinity. Taking into consideration the affinities these proteins
have for THs and the capillary transit times through tissues, albu-
min binds so weakly that the amount of TH that it delivers is
extremely low; thyroxine-binding globulin binds THs so tightly,
that the amount of TH it delivers is also low; whereas TTR binds
THs with an intermediate affinity rendering it the most signifi-
cant in terms of TH delivery to tissues [for a detailed quantitative
analysis, see Richardson (4)]. This can be seen as analogous to the
situation for Goldilocks and the Three Bears.
Once THs are bound to a TH distributor protein, with the
affinity determined by the on and off rates, the TH can dissociate
and enter a cell, either by diffusion (1) or via a membrane-bound
TH transporter (5). Inside the cell, the TH can then be activated
or inactivated by a family of enzymes called deiodinases (6). T4
is known as the “transport form” of TH, as it is the predomi-
nant form present in blood, whereas T3 is known as the “active
form” of TH as it has higher affinity for the TH receptors (7),
which are nuclear transcription factors. Thus, deiodinases can
activate T4 to T3, or can inactivate T4 to reverse T3 (rT3) or

























































Richardson Evolution of transthyretin functions
inactivate T3 to T2 (6). T3 can bind to cytosolic proteins and also
to the thyroid hormone receptors (TRs), which can translocate
into the nucleus, dimerize, recruit co-modulator proteins, and reg-
ulate transcription of specific genes. Many such genes are involved
in growth, development, and metabolism, a spectacular example
being metamorphosis of a tadpole (aquatic, herbivorous, gills, tail
for locomotion) to a frog (terrestrial, carnivorous, lungs, four limbs
FIGURE 1 |The structure of the main thyroid hormone thyroxine.
Thyroxine (3′,5′,3,5-tetraiodo-L-thyronone; T4) is the predominant form of
thyroid hormone secreted by the thyroid gland into the blood. T4 is
converted to T3 (5′,3,5,-triiodo-L-thyronine) by an enzymatic removal of an
iodine atom from the outer ring of T4. For example, the iodine atom circled
in red. Two enzymes that perform this function are deiodinase 1 (e.g., in the
liver) and deiodinase 2 (e.g., in the brain). T3 is the predominant form of
thyroid hormone that binds to the nuclear thyroid hormone receptors.
for locomotion) [see Shi (8)]. Thus, TTR is a member of one of
the five known classes of TH-binding proteins (TH distributor
proteins; TH transporter proteins; deiodinases; cytosolic proteins;
nuclear receptors) (Figure 2).
Transthyretin is a homo-tetramer, held together by non-
covalent interactions, without post-translational modifications.
Each subunit comprises eight β-strands that form two β-sheets
and a short region of α-helix (Figure 3). The holo-protein has
a central channel, which has two TH-binding sites (9); however,
under physiological conditions only one site is occupied, due to
negative co-operativity (10).
TTR NULL MICE HAVE A SUBTLY ALTERED PHENOTYPE, BUT
HUMANS LACKING TTR HAVE NOT BEEN DESCRIBED
Mice in which the TTR gene has been inactivated [TTR null
mice; (11)] have delayed development of several TH-regulated
events including central nervous system development, growth of
long bones, suckling-to-weaning transition (12), and adult TTR
null mice have a hypothyroid phenotype in the central nervous
system (13). Thus, the role of TTR in TH distribution in euthe-
rians has been demonstrated, despite having additional TH dis-
tributor proteins (albumin, TTR and thyroxine-binding globulin
FIGURE 2 |The five classes ofTH-binding proteins. T4 is the
predominant form of TH secreted by the thyroid gland in mammals. T4 is
the predominant form of TH in mammalian blood and T3 is also present in
significant quantities, but for simplicity T4 is the only form of TH shown in
blood in this schematic. More than 99% of TH (both T4 and T3) in blood is
bound to a TH distributor protein (1) e.g. albumin, transthyretin (TTR) or
thyroxine-binding globulin. TH can dissociate from its distributor protein
and enter cells via either TH transporters (2) or by diffusion. Inside the
cell, THs can be deiodinated by a family of deiodinases (3), which can
either activate (e.g. T4 to T3) or inactive (e.g. T3 to T2) the TH. THs can
bind to cytosolic proteins (4). Predominantly T3 binds to TH nuclear
receptors (5), which bind to specific regulatory regions of TH-regulated
genes and protein complexes to either promote or repress transcription
of those genes (4).

























































Richardson Evolution of transthyretin functions
FIGURE 3 |The structure of humanTTR. TTR is a homo-tetramer with a
central channel that contains two potential thyroid hormone binding sites.
Each subunit is rich in beta-sheet structure. Coordinates from
Blake et al. (9).
in the blood are all synthesized by the liver and secreted into
the blood). Humans lacking TTR have not been documented,
although humans lacking albumin and thyroxine-binding glob-
ulin have been reported [see Harms et al. (14)]. Possibly, this is
because TTR is the only TH distributor protein synthesized in
the central nervous system: in the choroid plexus, which forms the
blood–cerebrospinal fluid barrier. This TTR has been implicated in
moving TH from the blood into the cerebrospinal fluid (1, 15, 16).
SHORTENING OF THE N-TERMINAL REGION OF TTR
RESULTED IN CHANGING THE LIGAND FROM T3 TO T4
The amino acid sequence has been determined or derived from
cDNA sequences for TTRs from more than 20 vertebrate species
including teleost fish, amphibians, reptiles, birds, and mammals.
The amino acid sequence has been highly conserved throughout
vertebrate evolution, in particular, the amino acids which corre-
spond to regions involved in monomer–monomer interactions,
dimer–dimer interactions and those involved in TH binding [see
Prapunpoj et al. (17)]. The region of TTR which has changed the
most during vertebrate evolution is the N-terminal region, which
has changed from longer (e.g. in amphibians) to shorter (e.g. in
eutherian mammals). This has occurred in a step-wise manner,
which implies a specific and persistent selection pressure acting
on TTR during vertebrate evolution (Figure 4). Comparison of
the cDNA with the genomic DNA in this region for each species
revealed that the exon 1–exon 2 border was in the region of the gene
corresponding to the N-terminal region of the protein subunit.
Further analyses revealed that the position of the exon 1–intron 1
border did not change during vertebrate evolution. However, the
position of the intron 1–exon 2 border appears to have shifted in
the 3′ direction, in a step-wise manner, due to a series of single
base changes in the gene. Thus, the mechanism for the shortening
of the N-terminal regions of TTRs can be explained by a series of
changes in the gene that “moved” an increasing number of bases
from exon 2 into intron 1 (18) (Figure 5).
The effect of moving a series of bases of the TTR gene from
exon 2 to intron 1 shortened the N-termini of the TTR tetramer
but, most importantly, changed the function of TTR. Perhaps, this
was the driving selection pressure for the movement of the intron
1–exon 2 splice site in the 3′ direction.
Transthyretins with longer N-terminal regions (including those
from teleost fish, amphibians, reptiles and birds) have higher affin-
ity for T3 than for T4 (17, 19–22), whereas TTRs with shorter
N-terminal regions (including those from marsupials and euthe-
rians) have higher affinity for T4 (21) (Table 1). Thus, mammalian
TTRs are the exception binding T4>T3, as TTRs from all other
classes of vertebrates bind T3>T4. The hypothesis that binding
of T3 or T4 was due to the N-terminal regions of TTRs was tested
by two separate studies. The first study involved the purification of
TTR from chicken blood followed by elucidation of the X-ray crys-
tal structure of chicken TTR, to determine if there were structural
changes in the TH-binding site between human TTR (which pref-
erentially binds T4) and a TTR that preferentially bound T3. The
structure of the TH-binding site in chicken TTR did not differ to
that of human TTR (23). Thus, a different region of the molecule
must be responsible and the best candidates were the N-terminal
regions, which move freely in solution around the entrances to
the channel containing the TH-binding sites. The second study
involved a set of recombinant TTRs, including chimeric TTRs
whose N-terminal regions had been swapped (e.g. N-terminal
region of crocodile TTR attached to the “body” of human TTR
and vice versa). These TTRs were analyzed for their affinities to
T3 and T4. Indeed, the structure of the N-terminal regions did
influence the affinity and preference of ligand binding (24).
Thus, by shifting the position of the intron 1–exon 2 border,
TTR was able to change from being a T3 distributor to a T4 dis-
tributor. What could the selection pressure have been for changing
the ligand of TTR from T3 to T4? T3 is the active form of the
hormone whereas T4 is the pro-hormone. Perhaps, distributing
the pro-hormone could be considered safer than distributing the
active form of the hormone, requiring an additional level of acti-
vation of the pro-hormone by tissue-specific deiodinases, which
are very tightly regulated in terms of developmental and tissue-
specificity. In particular, this could be important in the central
nervous system, as in (for example) the rat brain, the proportion
of T3 generated by local deiodination of T4 is specific to the region
e.g. 65% in the cortex, 51% in the cerebellum, 35% in the pons,
32% in the hypothalamus, 30% in the medulla oblongata and 22%
in the spinal cord (25). Such tight regulation might not be pos-
sible if T3 were the predominant form of TH in the blood and
cerebrospinal fluid.
To put this into context, we should consider the total T4 and
total T3 levels in blood from various classes of vertebrates. A
comprehensive review by Hulbert (26) has tabulated the concen-
trations of T3 and T4 in the blood of more than 80 vertebrate
species (including several life stages for several species). In mam-
mals, birds and reptiles, the circulating levels of T4 are higher than
those of T3. However, in some amphibians and teleost fish, the
levels for circulating T3 and T4 are similar, while in other species
the levels of T4 are higher than those of T3. Of particular interest,

























































Richardson Evolution of transthyretin functions
FIGURE 4 | Alignment of representativeTTRs from various
vertebrate species. Amino acid sequences (and those derived from
cDNA sequences) of TTRs from species including eutherians,
marsupials, birds, reptiles amphibians, and a fish were aligned. Asterisks
indicate that amino acid is identical to that in human TTR. Gaps were
introduced to aid alignment. Residues in bold are the N-terminal amino
acid. Positions of introns are indicated by >. Residues in the central
channel are underlined (4).
those animals undergoing metamorphosis or smolting have the
characteristic peak in TH concentrations in their blood. In some
species, this has been correlated with a transient expression of
TTR (teleost fish; amphibian; reptile; polyprotodont marsupial) or
TBG (diprotodont marsupial) (27). Speculation as to the driving
force for greater control of T3 availability in specific brain areas
in mammals, as opposed to other vertebrates is very tempting, but
extremely speculative. Key TH-related features that distinguish
mammalian brains from those of other vertebrates include (i) the
corpus callosum and its extensive myelination and (ii) the highly
developed cerebral cortex. Furthermore, mammalian fetuses have
low levels of circulating T3 and maternal T4 (not T3) has a crucial
role in brain development (28).
THE TTR GENE AROSE AS A DUPLICATION OF THE TLP GENE
As mentioned earlier, the amino acid sequence of TTR has been
highly conserved during vertebrate evolution, to the extent that
the gene most likely arose prior to the divergence of vertebrates
from non-vertebrates. Therefore, open reading frames which
would code for transthyretin-like proteins (TLPs) were searched
for and identified (17). Subsequently, as increasing numbers of
genomes were sequenced, genes coding for more than 80 poten-
tial TLPs have been identified (and verified to be full-length
and not to contain in-frame stop codons, etc.) in all kingdoms
(29). Phylogenetic analysis revealed that TLP sequences gener-
ally clustered according to organism groups. Vertebrate TLPs
clustered together, close to TTRs. TTRs were only found in ver-
tebrate species, whereas TLP sequences were found in both verte-
brate and non-vertebrate species (29). Analyses of the TLP gene
sequences by signal-peptide prediction programs revealed that
TLPs could be divided into three groups: (1) those without sig-
nal peptides were predicted to be cytoplasmic, which included
most bacterial TLPs; (2) those with periplasmic localization sig-
nals, which were the enterobacteria; (3) those with peroxisomal

























































Richardson Evolution of transthyretin functions
FIGURE 5 | Mechanism of shortening of the N-terminal region ofTTR
during vertebrate evolution. (A) The position of the exon 1–intron 1 splice
site of the TTR precursor mRNA did not change during vertebrate evolution.
(B) The position of the intron 1–exon 2 splice site of the TTR precursor mRNA
shifted in the 3′ direction during vertebrate evolution. Double-headed arrows
indicate the positions of splice sites. Consensus splicing site sequences are
underlined. Asterisks indicate an identical base to that in human TTR
precursor mRNA. N-terminal regions are boxed (19).
(PTS2) signal peptides, which included TLPs from plants and
most metazoans (29) (Figure 6). Several bacterial species have
more than one copy of the TLP gene, often one copy that codes
for a cytoplasmic TLP and another copy coding for a periplas-
mic TLP (29). A neighbor-joining tree analyzing the relationship
between cytoplasmic and periplasmic TLPs showed that within a
given species, cytoplasmic TLPs clustered separately to periplas-
mic TLPs. For example, all periplasmic TLPs group together.
This suggested that periplasmic TLP sequences probably evolved
along a separate evolutionary pathway to cytoplasmic TLPs (30).
Thus, TLPs appear to have evolved different functions, depending
on their sub-cellular localization, rendering them very versatile
proteins. These characteristics of TLPs which result from the
variety of sub-cellular localizations contrast with TTRs, which are
secreted.
SUBTLE CHANGES IN THE ACTIVE SITE CHANGED TLPs
(ENZYMES INVOLVED IN URIC ACID OXIDATION) INTO TTRs
(THYROID HORMONE DISTRIBUTORS)
It was revealed by PCR that the TLP genes from a plant (A.
thaliana), a worm (C. elegans) and bacteria (E. coli and S. dublin)
were expressed in their respective species i.e. these open reading
frames were genes that were expressed in nature. The respective
cDNAs were cloned, sequenced and recombinant TLPs from these
species were synthesized and found to be tetramers, similarly to
TTR. However, these TLPs did not bind THs or TH analogs (29).

























































Richardson Evolution of transthyretin functions
Table 1 | Comparison of affinities ofTTRs forT4 andT3 (4).
Source ofTTR KdT4 (nM) KdT3 (nM) KdT3/KdT4
Eutherians
Human 13.6 56.6 4.2
Sheep 11.3 63.5 3.2
Rat 8.0 67.2 8.4
Marsupials
Wombat 21.8 97.8 4.5
Possum 15.9 206.1 12.9
Wallaby 13.8 65.3 4.7
Birds
Emu 37.4 18.9 0.51
Chicken 28.8 12.3 0.43
Pigeon 25.3 16.1 0.64
Reptile
Crocodile 36.7 7.56 0.21
Amphibian
Toad 508.0 248.0 0.49
FIGURE 6 | Predicted signal peptides ofTLPs. The signal-peptide
prediction predicted three main groups for TLPs: cytosolic (most bacteria),
periplasmic (enterobacteria) and peroxisomal (plants and most metazoans).
Data from Hennebry et al. (29).
The X-ray crystal structure of recombinant Salmonella dublin TLP
was determined (Figure 7A) and was completely superimposable
over those of vertebrate TTRs (31). The only differences were
subtle changes in the region equivalent to the TH-binding site.
Whereas in TTRs the binding site is deep and negatively charged,
the equivalent position in TLP was shallow, elongated and pos-
itively charged, thereby preventing binding of THs (Figure 7B).
Careful analysis of the operons within which several TLP genes
were situated, allowed the identification of TLP in (at least several)
bacteria as a 5-hydroxyisourate hydrolase (5-HIUase), involved in
the oxidation of uric acid to allantoin (Figure 8A). This was con-
firmed experimentally for S. dublin TLP, including identification
of some of the amino acids required for catalysis (Figure 8B)
(31) and has also been confirmed for TLP in Bacillus subtilis (32),
zebra fish (33), mouse (34), E. coli (35),Arabidopsis thaliana (36),
Klebsiella pneumonia (37), Coelacanth (38), amphioxus (39) and
rainbow trout (40).
An insightful paper by Cendron and colleagues (41) identified
two amino acid substitutions that were most probably fundamen-
tally critical for the modification of the TLP active site ablating
enzymatic activity and allowing opening up of the central chan-
nel to allow binding of THs. These are Ile to Ala at position 16
of zebrafish TLP (corresponding to position 19 of human TTR)
FIGURE 7 |The structure of Salmonella dublinTLP. (A). The X-ray crystal
structure of S. dublin TLP was that first TLP structure to be determined. The
overall structure is almost identical to that of human TTR. (B). The thyroid
hormone binding site in human TTR is deep and negatively charged,
whereas the equivalent site in S. dublin TLP is shallow and positively
charged (31).
and Tyr to Thr at position 116 of zebrafish TLP (corresponding
to position 119 of human TTR). Li and colleagues demonstrated
that in amphioxus (protochordate, close relative of vertebrates)
TLP, the point mutation Tyr to Thr at position 156 (correspond-
ing to position 116 in human TTR) was required for abolishing
5-HIUase activity and enabling T4 binding (39). While these muta-
tions were probably instrumental in changing the landscape of the
binding site from a shallow catalytic site to a deep channel, further
minor mutations were probably required to optimize the channel
for tighter binding of T3.
Interestingly, there are three splice variants of Arabidopsis
thaliana TLP: two are cytoplasmic and one is located in the per-
oxisome (36). The peroxisomal isoform has a 5-HIUase domain

























































Richardson Evolution of transthyretin functions
FIGURE 8 | Salmonella dublinTLP is a 5-hydroxyisourate hydrolase.
(A) The uricase pathway, responsible for the oxidation of uric acid to allantoin.
(B) Hydrolysis of 5-hydroxyisoirate (5-HIU) by S. dublin TLP and three mutated
forms: H6A, H95A and Y108F. Uric acid was added to the solution containing
uricase and 5-HIU was monitored at 312 nm. Maximum 5-HIU was generated
after 3 min and then spontaneously decomposed (black line). Addition of S.
dublin TLP resulted in rapid hydrolysis of 5-HIU (magenta line). Rapid
hydrolysis of 5-HIU did not occur for the mutants H6A, H95A and Y108F (31).
and an OHCU decarboxylase domain i.e. both enzymes occur in
the one transcript resulting in a bi-functional enzyme. There is
an internal peroxisomal signal peptide between the two domains
(N-terminal to the OHCU decarboxylase domain), presumably
targeting the bi-functional TLP to the peroxisome, where uric acid
degradation occurs. The function(s) of the cytoplasmic TLPs are
not yet known. Furthermore, teleost fish, whose genomes have
undergone an additional whole genome duplication, have two
forms of 5-HIUase. One form contains the peroxisomal signal
peptide and the other does not (40). Thus, in organisms where
there have been further TLP gene duplications, such as Arabidop-
sis and (at least some) teleost fish, there is further scope for
neo-functionalization of the TLP gene products i.e. the protein
resulting from the duplicated TLP gene could acquire a different
function by acceptance of point mutations in the duplicated gene
while the original TLP gene/protein remains unchanged.
IN SALMONELLA, TLP IS REQUIRED FOR SURVIVAL IN HIGH
URIC ACID ENVIRONMENTS
To demonstrate the function of Salmonella TLP in an animal
model, a Salmonella typhimurium TLP knock-out strain was gen-
erated and its survival was compared with that of wildtype Salmo-
nella typhimurium. The absence of TLP did not affect Salmonella
survival in mice, whether the Salmonella were injected into the tail
vein (and monitored for weight loss, development of enteric fever
and bacterial load in liver or spleen) or infected orally (and bacte-
rial load determined in Peyer’s Patches, mesenteric lymph nodes,
liver and spleen) (30). Consequently, it was reasoned that if TLP
was a 5-HIUase located in the periplasm of the Salmonella, then it
would be important for the survival of the Salmonella in high uric
acid environments such as the gastrointestinal tract of birds and
reptiles (uric acid is present in high amounts in feces of reptiles
and birds). Thus, mice might have been an inappropriate model
animal for testing the effect of TLP on Salmonella survival.
Hens were inoculated with either the wildtype or the TLP
knock-out strain of Salmonella. The feces of hens inoculated with
the TLP knock-out strain of Salmonella contained significantly
less live Salmonella than the feces of the hens inoculated with the
wildtype Salmonella (Figure 9) (30). This demonstrated that TLP
was important for the survival of Salmonella in high uric acid
environments. Thus, not only is it important to choose the most
appropriate animal model for such experiments, but this clearly
showed that TLP is important in the survival of Salmonella in high
uric acid environments.
MICE LACKING TLP SUFFER TOXICITY FROM URIC ACID
OXIDATION INTERMEDIATES
Mice lacking TLP were generated and found to have increased
thrombopoietin synthesis by the liver and enlarged livers
(hepatomegaly) resulting in increased platelet counts in the blood
(thrombocytosis). Most mice lacking TLP also developed hepato-
cellular carcinoma (42). It was concluded that this phenotype was
due to the toxic uric acid oxidation intermediates resulting from
the lack of 5-HIUase in the cytoplasm of the mouse hepatocytes.
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FIGURE 9 |TLP is required for survival of Salmonella typhimurium in
high uric acid environments such as chicken feces. (A). Numbers of
viable bacteria in the spleen, liver and cecum of hens 7 days after oral
inoculation with either wildtype Salmonella (open circles) or TLP null
Salmonella (closed circles). Horizontal lines: average number of bacteria per
organ; dotted line: lower detection limit of experiment. (B). Numbers of
viable bacteria in the feces of hens up to 21 days following oral inoculation
with either wildtype Salmonella (open circles) or TLP null Salmonella
(closed circles). Horizontal lines: average number of bacteria per gram
feces; dotted line: lower detection limit of experiment. There was a
significantly lower number of TLP null Salmonella than wildtype Salmonella
in the feces and each time point measured (30).
CONCLUSION
TLP/TTR is an excellent model for the study of protein evolution.
Notably because (i) it is found in all kingdoms, (ii) it has a stable
structure, (iii) it lacks post-translational modification, (iv) it can
be directed to many sites within a cell or secreted, (v) modification
of just a few amino acids in the active site changed its function
from a 5-HIUase to a T3 distributor, (vi) successive shifts in the
position of the intron 1–exon 2 splice site changed TTR from a
T3 distributor to a T4 distributor. Thus, apparently two different
molecular mechanisms have resulted in changes in the functions
of TLP/TTR. The functions of TLPs in plants and other organ-
isms are likely to be different to those in Salmonella or mice. The
differing signal peptides for the various groups of TLPs could be
interrogated in conjunction with RNAseq analyses to gain insights
into the functions of TLPs in various organisms. The suggestion
that cytoplasmic and periplasmic TLPs within a species evolved
in separate pathways suggests divergence of functions between
these groups of compartmentally distinct TLPs. Presumably, addi-
tional evolutionary mechanisms have also been used to modify the
functions of TLPs in each compartment in these species. These
mechanisms remain to be investigated.
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